Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding BBP?
Track your performance easily
BBP Price & Analysis
BBP ETF Chart & Stats
Day’s Range― - ―
52-Week Range$50.43 - $69.12
Previous Close$59.92
VolumeN/A
Average Volume (3M)1.19K
AUM20.96M
NAV59.84
Expense Ratio0.79%
Holdings Count63
Beta1.21
Inception DateDec 17, 2014
Last Dividend Ex-Date
Dec 20, 2017Dividend Yield
(―)Shares Outstanding350,004
Standard Deviation0.06
10 Day Avg. Volume1,039
30 Day Avg. Volume1,190
Alpha0.00088
Virtus LifeSci Biotech Products ETF (BBP) Fund Flow Chart
Virtus LifeSci Biotech Products ETF (BBP) 1 year Net Flows: $3M
BBP ETF News
BBP ETF FAQ
What was BBP’s price range in the past 12 months?
BBP lowest ETF price was $50.43 and its highest was $69.12 in the past 12 months.
What is the AUM of BBP?
As of Dec 19, 2024 The AUM of BBP is 20.96M.
Is BBP overvalued?
According to Wall Street analysts BBP’s price is currently Undervalued.
Does BBP pay dividends?
BBP pays a Notavailable dividend of $0.072 which represents an annual dividend yield of N/A. See more information on BBP dividends here
How many shares outstanding does BBP have?
BBP has 350,004 shares outstanding.
Which hedge fund is a major shareholder of BBP?
Currently, no hedge funds are holding shares in BBP
BBP ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Ironwood Pharmaceuticals
1.82%
Neurocrine Biosciences
1.78%
Harmony Biosciences Holdings, Inc.
1.77%
Ascendis Pharma A/S
1.76%
Tarsus Pharmaceuticals, Inc.
1.70%
Kiniksa Pharmaceuticals Ltd. Class A
1.70%
Apellis Pharmaceuticals
1.69%
Intra-Cellular Therapies
1.68%
TG Therapeutics
1.68%
Ligand Pharmaceuticals Inc
1.67%
Total17.25%
ETF Description
Virtus LifeSci Biotech Products ETF
BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider.